H.R.2641: Promoting Life-Saving New Therapies for Neonates Act of 2017

About This Bill

Bill Sponsor

Bill Version

Bill Summary

Promoting Life-Saving New Therapies for Neonates Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to award the sponsor of a new drug or biological product for the treatment of newborns a neonatal drug exclusivity voucher upon approval of the medication. A neonatal drug exclusivity voucher is a transferable voucher for a one-year extension of all existing patents and...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with H.R.2641.

Bill Actions

Date Description
May 26, 2017
Referred to the Subcommittee on Health.
May 24, 2017
Referred to the House Committee on Energy and Commerce.
May 24, 2017

Introduced in the House by Billy Long (R-Mo.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page